Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
20%
OVERLAP
BY WEIGHT
8
# OF OVERLAPPING
HOLDINGS
HRTS
44
HOLDINGS
18%
ALSO IN OZEM
OZEM
22
HOLDINGS
38%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.1% | 15.3% | 10.1% |
|
REGENERON PHARMACEUTICALS | 2.1% | 2.8% | 2.1% |
|
AMGEN INC | 2.0% | 3.5% | 2.0% |
|
GILEAD SCIENCES INC | 2.9% | 1.8% | 1.8% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 1.6% | 3.9% | 1.6% |
HRTS Overweight Relative to OZEM
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.9% |
|
UNITEDHEALTH GROUP INC | 4.5% |
 |
ASTRAZENECA PLC | 4.3% |
|
THERMO FISHER SCIENTIFIC INC | 4.1% |
|
MERCK & CO. INC. | 4.0% |
|
JOHNSON & JOHNSON | 4.0% |
|
ABBOTT LABORATORIES | 3.6% |
 |
NOVO NORDISK A/S-B | 3.4% |
|
BOSTON SCIENTIFIC CORP | 3.1% |
|
NOVARTIS AG | 3.0% |
HRTS Underweight Relative to OZEM
|
NOVO-NORDISK A/S-SPONS ADR | -22.0% |
|
ELI LILLY & CO | -5.2% |
|
ROCHE HOLDING LTD | -4.2% |
|
PFIZER INC | -4.0% |
 |
ASCLETIS PHARMA, INC. | -3.6% |
 |
INNOVENT BIOLOGICS, INC. | -3.6% |
 |
HANMI PHARM CO LTD | -3.4% |
|
SHANGHAI FOSUN PHARMACEUTI-H | -3.3% |
|
ZEALAND PHARMA A/S | -3.3% |
|
ASTRAZENECA PLC-SPONS ADR | -3.2% |